- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-L1 high TNBC
Total 25881 results
-
Gradalis, Inc.WithdrawnLung Neoplasms | Advanced Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingHead and Neck Squamous Cell CarcinomaUnited States, Australia, Brazil, Canada, China, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Monika Joshi, MDPfizer; Eisai Inc.; Big Ten Cancer Research ConsortiumTerminatedMetastatic Urothelial Cell CancerUnited States
-
Philipp FürnstahlKU Leuven; Swiss Center for Musculoskeletal ImagingCompleted
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Triple Negative Breast CancerAustralia
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Bristol-Myers SquibbWithdrawnStage III or IV Melanoma
-
Nasser Hanna, M.D.Merck Sharp & Dohme LLC; Hoosier Cancer Research NetworkTerminatedGenital Neoplasms, Female | Testicular Neoplasms | Genital Neoplasms, Male | Ovarian Neoplasms | Mediastinal Neoplasms | Germ Cell Neoplasms | Non Seminomatous Germ Cell TumorsUnited States
-
National Cancer Institute (NCI)TerminatedClear-Cell Renal CarcinomaUnited States
-
Asbjørn Mohr DrewesOdense University Hospital; Karolinska University Hospital; Hvidovre University... and other collaboratorsActive, not recruitingPancreatitis, AcuteDenmark, Sweden
-
Hoffmann-La RocheCompletedTumorsFrance, United States, Denmark, Ireland, Italy, Turkey, United Kingdom, Canada, Brazil, Spain, Poland, Netherlands, Germany, Russian Federation, Austria, Finland, Norway, Switzerland
-
Lee's Pharmaceutical LimitedRecruiting
-
National Cancer Institute (NCI)WithdrawnCastration Resistant Prostate CancerUnited States
-
Arjun Balar, MDHoosier Cancer Research Network; Roche-GenentechTerminatedUrothelial CarcinomaUnited States
-
Jounce Therapeutics, Inc.Completed
-
Merck Sharp & Dohme LLCRecruiting
-
Merck Sharp & Dohme LLCActive, not recruitingStomach NeoplasmsChina, Japan, Poland, Turkey, Brazil, United States, Argentina, Australia, Canada, Chile, Colombia, Costa Rica, Czechia, Denmark, France, Germany, Guatemala, Hong Kong, Hungary, Ireland, Israel, Italy, Korea, Republic of, Mexico, New Zealand and more
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
Merck Sharp & Dohme LLCCompletedSquamous Cell CarcinomaCanada, United States, Australia, France, Germany, Israel, Mexico, Norway, Spain, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruiting
-
Merck Sharp & Dohme LLCWithdrawn
-
Liza Villaruz, MDGenentech, Inc.RecruitingNon-small Cell Lung CancerUnited States
-
Hadassah Medical OrganizationRecruitingAminoglycoside Dosing Based on PK/PD CharacteristicsIsrael
-
ImmunityBio, Inc.TerminatedAdvanced Triple Negative Breast CancerUnited States
-
AbbVieTerminated
-
National Cancer Institute (NCI)RecruitingCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Non-Small Cell Lung Carcinoma | CarcinomasUnited States
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Australia, United States, Turkey, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand, Korea, Republic of
-
Merck Sharp & Dohme LLCRecruitingLymphoma, B-Cell | Lymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States, Australia, Canada, Germany, Israel, Italy
-
Merck Sharp & Dohme LLCEisai Inc.CompletedNon-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMetastatic Non-Small Cell Lung CancerRussian Federation, Australia, United States, Argentina, Canada, Colombia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Puerto Rico, Spain, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate Cancer
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedMelanomaAustralia, South Africa, Spain, Sweden
-
Mian XIRecruitingHepatocellular CarcinomaChina
-
National Cancer Center, KoreaRecruitingNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterRecruitingMetastatic Non-Small Cell Lung CarcinomaKorea, Republic of
-
Merck Sharp & Dohme LLCWithdrawnMultiple MyelomaUnited States, Canada, France, Israel, Spain, Sweden
-
Centre Hospitalier Princesse GraceAssistance Publique - Hôpitaux de Paris; Hospices Civils de Lyon; University... and other collaboratorsNot yet recruiting
-
Olivia Newton-John Cancer Research InstituteAustin Health; Roche Products Pty Limited; Ballarat Health ServicesActive, not recruitingFollicular LymphomaAustralia
-
Centre Hospitalier Universitaire de BesanconRoche Pharma AG; National Cancer Institute, FranceActive, not recruitingCervical Cancer | Squamous Cell Carcinoma of the Head and Neck | Anal Canal CancerFrance
-
National Cancer Institute (NCI)Not yet recruitingStage II Squamous Cell Carcinoma of the Head and Neck | Stage III Squamous Cell Carcinoma of the Head and Neck | Stage IV Squamous Cell Carcinoma of the Head and NeckUnited States
-
Genzyme, a Sanofi CompanyDiacrin/Genzyme Corporation LLCCompleted
-
University of Erlangen-Nürnberg Medical SchoolRecruitingRenal Cell Carcinoma | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Squamous Cell Carcinoma of the Skin | Small Cell Bronchial CarcinomasGermany
-
The First Affiliated Hospital of Zhengzhou UniversityRecruiting
-
Sohag UniversityNot yet recruitingNasopharyngeal and Hypopharyngeal CarcinomaEgypt